Type 1 Diabetes

At the virtual Scientific Sessions for the American Diabetes Association, the future of treatment for type 2 diabetes is discussed.

A session at the virtual Scientific Sessions for the American Diabetes Association examines the role food insecurity may play in glycemic control and acute complication among type 2 diabetes patients.

The impact of nutrition in the first years of life on future cardiometabolic health has been generally understood, although gaps about certain populations remain. A session at the virtual Scientific Sessions for the American Diabetes Association sought to fill the gap for Native American children.

Low socioeconomic status is a main driver of disparities in health care. A presentation at the virtual Scientific Sessions for the American Diabetes Association addressed how they impact pediatric diabetes care.

For many underserved type 1 diabetes patients the ability to seek specialist care is out of reach for a variety of reasons. One program discussed at the virtual Scientific Sessions for the American Diabetes Association seeks to change that by empowering primary care providers through education to provide much-needed specialist care to those patients.

Disparities in type 1 diabetes care can influence long-term outcomes. A presentation at the virtual Scientific Sessions for the American Diabetes Association examined how the Novel Interventions in Children's Healthcare program performed in reducing inequities in outpatient care access.

Although the mental toll of the pandemic has been high for everyone, it’s been especially difficult for children with chronic diseases such as type 1 diabetes. A session at the virtual Scientific Sessions for the American Diabetes Association addressed how one program tackled these concerns.

Diabetic eye examinations are an important way to improve outcomes for diabetic retinopathy, but are some children missing out?

Previous research has shown that type 1 diabetes can impact the brain. A study examines whether this impact can persist or even worsen.

Golimumab has shown great promise in treating autoimmune conditions. An investigation looks into whether patients with type 1 diabetes may also benefit from the drug.

The US Food and Drug Administration (FDA) has approved Medtronic’s hybrid closed loop diabetes management device for use in children aged 2 to 6 years.

Type 1 diabetes treatment has improved dramatically over the years. A new study examines the efficacy of a closed loop system.

A new study connects an asthma diagnosis to type 1 diabetes (T1D) development later in life but also shows that the opposite may not be true.

The rising prevalence in childhood obesity increases the risk of teenagers and adolescents developing conditions linked to excess weight like type 2 diabetes, a condition long considered to be a disease for older people. A recent study in JAMA Pediatrics indicates that many adolescents and young adults have prediabetes, the stepping stone to type 2 diabetes.

Clinicians may be able to identify patients at the highest risk of developing type 1 diabetes with a simple saliva test.

Patients with diabetes have an increased risk of developing depression. A new study in Pediatric Diabetes, however, takes this one step further, suggesting that depressive symptoms among youths with diabetes varies by diabetes type. 

A liver disease that causes inflammation and cell damage is common in children with type 2 diabetes, but lifestyle changes and medication may help.

Children who are overweight or obese are potentially at risk for developing diabetes, but there’s more to identifying prediabetes than just obesity.